M. Shinoda

发表

E3710, a New Proton Pump Inhibitor, with a Long-Lasting Inhibitory Effect on Gastric Acid Secretion

J. Nagakawa, K. Hirota, H. Terauchi, 2010, Journal of Pharmacology and Experimental Therapeutics.

3710 , a New Proton Pump Inhibitor , with a Long-Lasting Inhibitory Effect on Gastric Acid Secretion

J. Nagakawa, K. Hirota, H. Terauchi, 2010 .

Effects of the Combination of a Dipeptidyl Peptidase IV Inhibitor and an Insulin Secretagogue on Glucose and Insulin Levels in Mice and Rats

T. Saeki, E. Yamamoto, K. Yamazaki, 2007, Journal of Pharmacology and Experimental Therapeutics.

7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one Is a Novel Competitive and Selective Inhibitor of Dipeptidyl Peptidase IV with an Antihyperglycemic Activity

T. Saeki, K. Yamazaki, M. Shinoda, 2006, Journal of Pharmacology and Experimental Therapeutics.

ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model

M. Shinoda, N. Nagakura, S. Kobayashi, 1998, Inflammation Research.

Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.

T. Inoue, T. Kawahara, M. Shinoda, 1994, Journal of medicinal chemistry.

Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs.

Hitoshi Harada, Hideki Yoshitomi, H. Yoshitomi, 2008, Journal of pharmacological sciences.

Effects of ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor, on indices of early articular lesion in MRL/MpJ-lpr/lpr mice

M. Shinoda, N. Nagakura, S. Kobayashi, 1999, Inflammation Research.

Structure-Activity Relationships of (E)-3-(1,4-Benzoquinonyl)-2-((3- pyridyl)alkyl)-2-propenoic Acid Derivatives That Inhibit Both 5- Lipoxygenase and Thromboxane A2 Synthetase.

I. Yamatsu, T. Kawahara, M. Shinoda, 1996 .

Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.

I. Yamatsu, K. Miyamoto, T. Kawahara, 1996, Journal of medicinal chemistry.

Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs.

H. Yoshitomi, H. Harada, M. Shinoda, 2008, Journal of Pharmacological Sciences.